SARS-CoV-2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective

Cell Biol Int. 2022 Jul;46(7):1009-1020. doi: 10.1002/cbin.11800. Epub 2022 Apr 2.

Abstract

Almost a century after the devastating pandemic of the Spanish flu, humankind is facing the relatively comparable global outbreak of COVID-19. COVID-19 is an infectious disease caused by SARS-CoV-2 with an unprecedented transmission pattern. In the face of the recent repercussions of COVID-19, many have argued that the clinical experience with influenza through the last century may have tremendous implications in the containment of this newly emerged viral disease. During the last 2 years, from the emergence of COVID-19, tremendous advances have been made in diagnosing and treating coinfections. Several approved vaccines are available now for the primary prevention of COVID-19 and specific treatments exist to alleviate symptoms. The present review article aims to discuss the pathophysiology, diagnosis, and treatment of SARS-CoV-2 and influenza A virus coinfection while delivering a bioinformatics-based insight into this subject matter.

Keywords: COVID-19; SARS-CoV-2; bioinformatics perspective; coinfection; influenza.

Publication types

  • Historical Article
  • Review

MeSH terms

  • COVID-19*
  • Coinfection* / diagnosis
  • Coinfection* / epidemiology
  • Computational Biology
  • History, 20th Century
  • Humans
  • Influenza Pandemic, 1918-1919*
  • Influenza, Human* / epidemiology
  • Influenza, Human* / prevention & control
  • Orthomyxoviridae*
  • SARS-CoV-2